Viewing nowOlmesartan Medoxomil 20 mg Tablet
Olmesartan Medoxomil 20mg
Tablet · Prescription medication
L&C Bio Co., Ltd.

MFDS item code 202002234 · Approved 2020.03.31 · Insurance code 060500650
Treatment of essential hypertension
Essential hypertension is a condition characterized by persistently high blood pressure, which can place stress on the heart and blood vessels. This medication helps to reliably lower blood pressure and protect heart and vascular health. Through consistent treatment, it can reduce the risk of complications and help maintain a smooth daily life. Therefore, it is used for the treatment of essential hypertension.
<Adults> The recommended initial dose is 10 mg once daily, administered regardless of meals. If blood pressure is not adequately controlled at this dose, increase to 20 mg once daily. If additional blood pressure reduction is required, the dose may be increased to a maximum of 40 mg once daily. The antihypertensive effect appears within 2 weeks after starting treatment, with the maximum effect seen at approximately 8 weeks. If blood pressure is not controlled with this drug alone, it may be administered in combination with a thiazide diuretic such as hydrochlorothiazide. To improve adherence, it is recommended that the drug be taken at the same time each day, if possible (e.g., in the morning). For patients who may have reduced effective intravascular volume (e.g., patients receiving diuretics, particularly those with renal impairment), it is recommended to start treatment at a low dose while closely monitoring their condition. <Elderly> No dosage adjustment is required when this drug is administered to patients aged 65 years or older. Although no overall differences in efficacy or safety have been observed between elderly and younger patients, the possibility of a more sensitive response in some elderly patients cannot be excluded. <Patients with renal impairment> The maximum dose for patients with mild or moderate renal impairment (creatinine clearance 20-60mL/min) is 20mg once daily. <Patients with hepatic impairment> No dosage adjustment is required for patients with mild hepatic impairment. The recommended initial dose for patients with moderate hepatic impairment is 10mg once daily, which may be increased to a maximum of 20mg once daily. Use is not recommended in patients with severe hepatic impairment because there is no experience with its use in these patients.
<Pediatric patients> The safety and efficacy in pediatric patients have not been established.
This medication can cause serious harm to the fetus and newborn if taken during pregnancy, especially in the second and third trimesters, so it should be discontinued immediately once pregnancy is confirmed. It should not be used in patients with allergies to any of the ingredients, in pregnant or nursing women, patients undergoing renal dialysis, patients with severe liver dysfunction, patients with bile duct obstruction, certain genetically predisposed lactose intolerant patients, and specific diabetic patients or patients with moderate to severe renal function impairment. Patients with reduced blood volume or sodium may experience hypotension, so conditions should be monitored closely prior to administration and appropriate measures should be taken as necessary. Patients with renal impairment, renal transplant recipients, patients with renovascular hypertension, patients at risk of hyperkalemia, and patients with aortic and mitral stenosis should use this medication with caution and avoid dangerous tasks or driving due to symptoms of dizziness caused by blood pressure reduction. This medication may cause relatively mild side effects such as dizziness, headache, back pain, dyspepsia, and cough, while serious reactions such as facial swelling or angioedema have been reported rarely. If symptoms similar to chronic malabsorption syndrome, such as chronic diarrhea and weight loss occur, the use of this medication should be discontinued, and if symptoms of intestinal angioedema arise, treatment should be stopped immediately and monitored. Interactions may occur when taken with potassium-sparing diuretics, potassium supplements, lithium, and non-steroidal anti-inflammatory drugs, so caution is needed. Due to the risks to the fetus and newborn during pregnancy, this medication should be discontinued if pregnancy occurs, and nursing women should consider stopping breastfeeding or the medication, as it might affect the baby. Safety in children has not been established, so caution is advised for use, and elderly patients may require dose adjustments due to potentially increased levels of the drug in the body. In case of overdose, symptoms such as hypotension and palpitations may appear, and appropriate treatment should be administered if necessary.
Not everyone experiences these, and they can vary from person to person.
This medication is sensitive to air and moisture and should be stored in a tightly sealed container. It is recommended to store it at room temperature, specifically between 1 degree and 25 degrees Celsius.
White round film-coated tablet
30 tablets/bottle, 100 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowOlmesartan Medoxomil 20mg
Tablet · Prescription medication
L&C Bio Co., Ltd.

Olmesartan Medoxomil 20mg
Tablet · Prescription medication
Daewoong Pharmaceutical Co., Ltd.

Olmesartan Medoxomil 10mg
Tablet · Prescription medication
Daewoong Pharmaceutical Co., Ltd.

Olmesartan Medoxomil 40mg
Tablet · Prescription medication
Daewoong Pharmaceutical Co., Ltd.

Olmesartan Medoxomil 10mg
Tablet · Prescription medication
Hana Pharmaceutical Co., Ltd.

Olmesartan Medoxomil 10mg
Tablet · Prescription medication
Jongkeundang Co., Ltd.

Olmesartan Medoxomil 20mg
Tablet · Prescription medication
Jongkundang Co., Ltd.

Olmesartan Medoxomil 20mg
Tablet · Prescription medication
Jinyang Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.